Breaking News
Investing Pro 0
Free Webinar - What Is a Gold IRA? Fees, Advantages, and Risks - December 7, 2022 | 01:00PM EST Enroll Now
Close

Histogen Inc (HSTO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Histogen Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.0125 -0.0375    -3.57%
06/12 - Closed. Currency in USD ( Disclaimer )
Pre Market
1.0300
+0.0175
+1.7284%
7:38:58 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 28,534
  • Bid/Ask: 1.0200 / 1.0400
  • Day's Range: 0.9750 - 1.0500
Histogen Inc 1.0125 -0.0375 -3.57%

HSTO Earnings

 
The latest earnings per stock, revenues and financial reports for Histogen Inc (HSTO).
InvestingPro Earnings Insights
Latest Release

Nov 10, 2022

EPS / Forecast

-1.01 / -1.49

Revenue / Forecast

5K / 0.00

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Mar 09, 2023 12/2022 -- /  -1.11 -- /  0.00
Nov 10, 2022 09/2022 -1.01 /  -1.49 5K /  0.00
Aug 11, 2022 06/2022 -1.55 /  -2 5K /  0.00
May 12, 2022 03/2022 -0.2 /  -1.5 3.76M /  0.00
Mar 10, 2022 12/2021 -1.4 /  -0.105 5K /  0.00
Nov 10, 2021 09/2021 -0.09 /  -0.115 591K /  0.00
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HSTO Comments

Write your thoughts about Histogen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Hold This Sheet
Hold This Sheet Apr 18, 2022 11:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s the bad news?
Wouter Kremer
Wouter Kremer Apr 12, 2022 2:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pt 47Trading at 90.9% below our estimate of its fair valueRevenue is forecast to grow 63.32% per yearRisk AnalysisEarnings have declined by 51.3% per year over past 5 yearsShareholders have been substantially diluted in the past yearDoes not have meaningful revenue ($1M)Does not have a meaningful market cap ($29M)
Ron Barry
Ron Barry Jul 27, 2021 10:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
last week to get in on evfm, before quarter results are in. expectedly good..
Hyborian War
HyborianWar Jun 28, 2021 11:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DMA200 currently 1.3x setup for a GC move as well
Hyborian War
HyborianWar Jun 23, 2021 9:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lets go🥳🚀🚀🚀
Abe Martin
Abe Martin Mar 09, 2021 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hope some of the guys losing hair from reddit due to GME going up and down start buying HSTO, plenty of shorting to fight here too.
Hyborian War
HyborianWar Mar 09, 2021 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's ON 🚀🚀
Ja Grew
Ja Grew Mar 09, 2021 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
that's the problem with pharma shares, they fall for a reason on firm's results of expts. if expt fails , share go down for a long time. so get out of it.
Moe Yon
Receive Mar 05, 2021 9:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it going up soon?
Fermin Meneses
Fermin Meneses Mar 04, 2021 7:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.smarteranalyst.com/new-blurbs/histogen-hsto-has-a-new-rating-from-canaccord-genuity/
Abe Martin
Abe Martin Feb 16, 2021 10:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great news this week, seems like the alopecia treatment tests are still going great. I hope this stock can get back up and my hair back into my head and not in my shoulders or ears :D. I hope they can find something for those ones to migrate somewhere else haha
Abe Martin
Abe Martin Feb 08, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hope they get somewhere, it seems promising their work in knee cartilage regeneration and everyone will want to recover some of the hair lost from the stress of 2020 and 2021. Everyone bothered by losing hair or knee pain should invest here!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email